missing translation for 'onlineSavingsMsg'
Learn More

Doxazosin mesylate, MedChemExpress

Product Code. 16492006
Encompass_Preferred
Click to view available options
Quantity:
500 mg
1 g
Unit Size:
1g
500mg
This item is not returnable. View return policy

Product Code. 16492006

Brand: Medchem Express HYB0098A

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Doxazosin mesylate (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.

Doxazosin mesylate (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.

Specifications

Chemical Name or Material Doxazosin mesylate
CAS 77883-43-3
Color White
Purity Grade Notes Research
Molecular Formula C24H29N5O8S
Quantity 500 mg
Synonym UK 33274 mesylate
Solubility Information DMSO : 33.33 mg/mL (60.87 mM; Need ultrasonic) ∣H2O : 1 mg/mL (1.83 mM; Need ultrasonic)
SMILES O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OC5=CC=CC=C5OC4.CS(=O)(O)=O
Molecular Weight (g/mol) 547.58
Formula Weight 547.58
Percent Purity 99.72%
Grade Research
Physical Form Solid
For Use With (Application) COVID-19-immunoregulation
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.